兴齐眼药：伏立康唑滴眼液II期临床试验首例受试者入组

Core Viewpoint - The company has initiated the Phase II clinical trial for its developed Voriconazole eye drops, marking a significant step in exploring the drug's efficacy and safety for fungal keratitis patients [1] Group 1: Clinical Trial Details - The Phase II clinical trial is a randomized, positive-controlled, multi-center exploratory study [1] - The trial aims to preliminarily assess the efficacy and safety of Voriconazole eye drops in subjects with fungal keratitis [1] - The results from this trial will inform the exploration of safe and effective drug concentrations for the subsequent Phase III clinical trial [1]